Discovery and development of Boceprevir, an HCV NS3 protease inhibitor, for the treatment of hepatitis C infection

被引：0

作者：

Howe, Anita ^{[1
]}

机构：

[1] Merck Reserach Lab, Kenilworth, NJ 07033 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 243卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

365-BIOL

引用

页数：1

共 50 条

[31] Treatment of HCV infection with the novel NS3/4A protease inhibitors
De Luca, Andrea
Bianco, Claudia
Rossetti, Barbara
CURRENT OPINION IN PHARMACOLOGY, 2014, 18 : 9 - 17
[32] Hepatitis C virus NS3 serine protease as a drug discovery target
McPhee, F
Yeung, KS
Good, AC
Meanwell, NA
DRUGS OF THE FUTURE, 2003, 28 (05) : 465 - 488
[33] Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C
Foote, Bryce S.
Spooner, Linda M.
Belliveau, Paul P.
ANNALS OF PHARMACOTHERAPY, 2011, 45 (09) : 1085 - 1093
[34] Solution conformations of the substrates and inhibitor of hepatitis C virus NS3 protease
Lee, JH
Bang, K
Jung, JW
Ahn, IA
Ro, S
Lee, W
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 1999, 20 (03) : 301 - 306
[35] The therapeutic potential of NS3 protease inhibitors in HCV infection
Goudreau, N
Llinàs-Brunet, M
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (09) : 1129 - 1144
[36] Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir
McPhee, Fiona
Friborg, Jacques
Levine, Steven
Chen, Chaoqun
Falk, Paul
Yu, Fei
Hernandez, Dennis
Lee, Min S.
Chaniewski, Susan
Sheaffer, Amy K.
Pasquinelli, Claudio
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3670 - 3681
[37] BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN
Kukolj, G.
Benhamou, Y.
Manns, M. P.
Bourliere, M.
Pol, S.
Schuchmann, M.
Cartier, M.
Huang, D.
Lagace, L.
Steinmann, G.
Stern, J. O.
JOURNAL OF HEPATOLOGY, 2009, 50 : S347 - S347
[38] Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease
Sheng, X. Christopher
Appleby, Todd
Butler, Thomas
Cai, Ruby
Chen, Xiaowu
Cho, Aesop
Clarke, Michael O.
Cottell, Jeromy
Delaney, William E.
Doerffler, Edward
Link, John
Ji, Mingzhe
Pakdaman, Rowchanak
Pyun, Hyung-Jung
Wu, Qiaoyin
Xu, Jie
Kim, Choung U.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2629 - 2634
[39] Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)
Llinas-Brunet, Montse
Bailey, Murray D.
Goudreau, Nathalie
Bhardwaj, Punit K.
Bordeleau, Josee
Boes, Michael
Bousquet, Yves
Cordingley, Michael G.
Duan, Jiamin
Forgione, Pat
Garneau, Michel
Ghiro, Elise
Gorys, Vida
Goulet, Sylvie
Halmos, Ted
Kawai, Stephen H.
Naud, Julie
Poupart, Marc-Andre
White, Peter W.
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (17) : 6466 - 6476
[40] Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
Harper, Steven
McCauley, John A.
Rudd, Michael T.
Ferrara, Marco
DiFilippo, Marcello
Crescenzi, Benedetta
Koch, Uwe
Petrocchi, Alessia
Holloway, M. Katharine
Butcher, John W.
Romano, Joseph J.
Bush, Kimberly J.
Gilbert, Kevin F.
McIntyre, Charles J.
Nguyen, Kevin T.
Nizi, Emanuela
Carroll, Steven S.
Ludmerer, Steven W.
Burlein, Christine
DiMuzio, Jillian M.
Graham, Donald J.
McHale, Carolyn M.
Stahlhut, Mark W.
Olsen, David B.
Monteagudo, Edith
Cianetti, Simona
Giuliano, Claudio
Pucci, Vincenzo
Trainor, Nicole
Fandozzi, Christine M.
Rowley, Michael
Coleman, Paul J.
Vacca, Joseph P.
Summa, Vincenzo
Liverton, Nigel J.
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (04): : 332 - 336

← 1 2 3 4 5 →